CYTK Sale Disclosure
Malik Fady Ibraham · SEC Form 4 · Filed Nov 3, 2026
Sale
Calculated transaction value
$220.25K
Malik Fady Ibraham EVP Research & Development
CYTK
Cytokinetics Inc
CYTK
Transaction date
Nov 3, 2026
Public filing date
Nov 3, 2026
Filing lag
Filed same day
CYTK daily price context
Close on/before transaction
$62.31
Nov 3, 2026
First close after public filing
$63.6
Nov 4, 2026
Return after filing · so far
-15.58%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,500 shares @ $62.93
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001061983-26-000108
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$247.56K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Cytokinetics Inc CYTK | Exercise | Nov 3, 2026 | $27.3K |
| Cytokinetics Inc CYTK | Exercise | Nov 3, 2026 | $0 |
| Cytokinetics Inc CYTK Current | Sale | Nov 3, 2026 | $220.25K |